Understanding how a specific protein affects insulin production in adult human pancreatic cells
Official title: Molecular mechanisms of NKX2.2 function in adult human beta cells
Funded at Vanderbilt University · NIH-11000806 · Data updated 2026-11-12
This study is looking at how a protein called NKX2.2 affects insulin production in the cells that help control blood sugar, which is important for people with type 2 diabetes, to find out more about how diabetes works and possibly discover new treatments.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | January 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $34,690 |
| NIH project number | 5F30DK134041-03 |
| Project ID | NIH-11000806 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults diagnosed with type 2 diabetes or those at risk of developing the condition.
✕Less likely to help
Patients with type 1 diabetes or those without any form of diabetes may not benefit from this research.
What this research studies
This research investigates the role of the NKX2.2 protein in regulating insulin secretion from adult human pancreatic beta cells, which are crucial for maintaining blood sugar levels. By using advanced techniques like CRISPR/Cas9 to modify these cells, the researchers aim to uncover how NKX2.2 influences beta cell function and contributes to the development of type 2 diabetes. The study will involve analyzing changes in cell signaling and function in specially prepared human cell models. This could lead to a better understanding of diabetes mechanisms and potential new treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for type 2 diabetes by enhancing our understanding of insulin regulation.
How similar studies have gone: Previous research has shown promising results in understanding beta cell function through similar molecular approaches, indicating potential for success in this area.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Pettway, Yasminye D — Vanderbilt University
- Study coordinator: Pettway, Yasminye D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.